Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 39 209,51 ₴, with a 24-hour trading volume of 66B ₴. The asset's market cap is 35,03T ₴, after moving -2.40% in the last day.
Tokenized Eli Lilly And Co is trading at 39 310,89 ₴, with a tokenized market cap of 215,92M ₴ and a 24-hour trading volume of 96,31M ₴. The tokenized asset has moved -3.62% in the past 24 hours.